VTR Stock Ventas, Inc.
US · NYSELast in our picks 2026-10-22 — not in the current list; analysis below is from that screen
Senior-housing recovery and improving occupancy provide operating leverage across a high-quality healthcare portfolio.
Future value: $100.50 (+17.71%) · 6-12 months · analyst consensus
Signal breakdown
- ▸Occupancy recovery and demographic tailwinds support improving same-store performance.
- ▾Below 50-day MA (-2.99%)
Is VTR a buy right now?
Trend: VTR is trading below the 50-day average (-0.43%), RSI 64 — neutral momentum, with a 3-month return of -10.90%.
Valuation & quality: Ventas, Inc. trades on a trailing P/E of 161.9, forward P/E 110.7, PEG 4.95, price-to-book 3.06; fundamentals show net margin 4.1%, return on equity 2.0%, revenue growth 21.7% year on year.
Analyst consensus: 22 analysts have a mean 12-month price target of $100.50 (+14.9% vs the last close; range $90.00 – $113.00), consensus rating “buy”.
Income: trailing dividend yield 2.40%.
Our screen: ACCUMULATE (score 1) — Senior-housing recovery and improving occupancy provide operating leverage across a high-quality healthcare portfolio.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -5.10% | +7.40% | -3.90% | +5.20% | +5.30% | -2.50% | -6.70% | +2.80% |
Fundamentals
Analyst price target
Technical signals
About Ventas, Inc.
Ventas, Inc. is an S&P 500 company enabling exceptional environments that benefit a large and growing aging population. With approximately 1,450 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy.
Sector: Real Estate · Industry: REIT - Healthcare Facilities · United States · 542 employees · Website
Related Real Estate picks
Browse: all US stocks · Real Estate picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.